閔元增


/uploads/image/2019/06/17/211e69239d568adfcc5eb5907c90fd41.jpg 姓 名: 閔元增
 地 址:中國科學技術大學化學系
 電 話:86-551-63601817
 電 郵:minyz@ustc.edu.cn




/uploads/image/2019/01/08/cfe1cd36d60b7f1c06e6497144a0d8cc.jpg

 教育與科研經歷
  2008.09-2012.04中國科學技術大學,生物無機化學,博士
  2012.08-2014.01

加坡南洋理工大學,化學與生物化學系,博士后(合作導師:Bengang Xing教授)

  2014.01-2017.06美國北卡萊羅納大學教堂山分校(UNC Chapel Hill),醫學院(UNC Lineberger Comprehensive Cancer Center)和癌癥納米技術卓越中心(Centers of Cancer Nanotechnology Excellence,CCNEs),博士后(合作導師:AIMBE fellow、臨床放療醫生Andrew Wang教授;共同導師是臨床醫生Jonathan S. Serody教授)
  2017.07-2018.09美國北卡萊羅納大學教堂山分校(UNC Chapel Hill),UNC Lineberger Cancer Center,博士后(合作導師:美國三院院士Joseph M. DeSimone教授)
  2018.09-2019.03中國科學技術大學化學系,特任研究員
  2019.04-至今中國科學技術大學化學系,特任教授


/uploads/image/2019/01/08/cfe1cd36d60b7f1c06e6497144a0d8cc.jpg

 目前研究方向(化學生物學/納米生物醫學)
  1.腫瘤免疫治療相關的納米技術
  2.生物分子成像
  3.腫瘤放療增敏
  4.3D打印材料及其生物醫學工程中的應用


/uploads/image/2019/01/08/cfe1cd36d60b7f1c06e6497144a0d8cc.jpg

 在研科研項目

中國科學技術大學科研啟動基金(2019-2022)


/uploads/image/2019/01/08/cfe1cd36d60b7f1c06e6497144a0d8cc.jpg

 代表性論文
  1.Xiaomeng Wan (#), Yuanzeng Min (#), Herdis Bludau, Andrew Keith, Sergei S. Sheiko, Rainer Jordan, Andrew Z. Wang, Marina Sokolsky-Papkov, and Alexander V. Kabanov (*). Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer. ACS Nano, 2018, 12 (3), 2426-2439(與美國發明家院士Kabanov教授的合作論文)
  2.Yuanzeng Min, Kyle C. Roche, Shaomin Tian, Michael J. Eblan, Karen P.McKinnon, Joseph M. Caster, Shengjie Chai, Laura E. Herring, Longzhen Zhang, Tian Zhang, Joseph M. DeSimone, Joel E. Tepper, Benjamin G. Vincent, Jonathan S. Serody and Andrew Z. Wang (*). Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology, 2017, 12 (9), 877-882.
  3.Edina C. Wang (#), Yuanzeng Min (#), Robert C. Palm, James J. Fiordalisi, Kyle T. Wagner, Nabeel Hyder, Adrienne D. Cox, Joseph M. Caster, Xi Tian, and Andrew Z. Wang (*). Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors. Biomaterials, 2015, 51, 208-215
  4.Kin Man Au, Yuanzeng Min, Xi Tian, Longzhen Zhang, Virginia Perello, Joseph M. Caster, and Andrew Z. Wang (*). Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles. ACS Nano, 2015, 9 (9), 8976-8996
  5.Yuanzeng Min (#), Joseph M. Caster (#), Michael J. Eblan, and Andrew Z. Wang (*). Clinical Translation of Nanomedicine. Chemical Reviews, 2015, 115 (19), 11147-11190.
  6.Yuanzeng Min, Jinming Li, Fang Liu, Edwin K. L. Yeow (*), and Bengang Xing (*). Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. Angewandte Chemie Internatinal Edition, 2014, 53 (4), 1012-1016
  7.Yuanzeng Min, Cheng-Qiong Mao, Siming Chen, Guolin Ma, Jun Wang (*), and Yangzhong Liu (*). Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System. Angewandte Chemie Internatinal Edition, 2012, 51 (27), 6742-6747


相關文章

baijiale|官网登录